Recent Quotes (30 days)

You have no recent quotes
chg | %

Novartis AG (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 183   

Articles published

NVS 86.16 +1.22 (1.44%)
price chart
Immunize Juno Therapeutics Inc (JUNO) Stock With This Trade
Novartis AG (ADR) (NYSE:NVS) recently secured the first-ever FDA approval for a CAR-T cancer therapy. As much and as InvestorPlace's James Brumley thoughtfully detailed earlier this week, the combined actions of Gilead and Novartis are significant for ...
Cadence Bank Na Lowered Its Novartis Ag Sponsored Adr (NVS) Position; Shorts ...
Cadence Bank Na decreased Novartis Ag Sponsored Adr (NVS) stake by 33.96% reported in 2016Q4 SEC filing. Cadence Bank Na sold 12,055 shares as Novartis Ag Sponsored Adr (NVS)'s stock rose 4.17%. The Cadence Bank Na holds 23,440 shares ...
Cadence Design Systems (CDNS) Analysts See $0.24 EPS; First Financial Trimmed ...
First Financial Corp decreased Novartis Ag Spnsrd Adr (NVS) stake by 72.34% reported in 2017Q2 SEC filing. First Financial Corp sold 8,347 shares as Novartis Ag Spnsrd Adr (NVS)'s stock rose 4.17%. The First Financial Corp holds 3,191 shares with ...
Novartis AG Adr (NVS) Market Value Rose While Bradley Foster & Sargent INC ...
Bradley Foster & Sargent Inc decreased its stake in Novartis A G Adr (NVS) by 45.21% based on its latest 2016Q4 regulatory filing with the SEC.
Pacer Advisors Inc. Purchases Shares of 22030 Novartis AG (NYSE:NVS)  Newburgh Gazette
John G Ullman & Associates INC Holding in Novartis Ag (NVS) Boosted by ...  BZ Weekly
Klingenstein Fields & Co Upped Its Novartis Ag Sponsored Adr (NVS) Holding ...
Klingenstein Fields & Co Llc increased Novartis Ag Sponsored Adr (NVS) stake by 89.01% reported in 2016Q4 SEC filing.
Novartis AG (ADR) (NVS) Reaches $84.67 After 4.00% Up Move; Morgan Stanley ...
The stock of Novartis AG (ADR) (NYSE:NVS) is a huge mover today! About 472,941 shares traded. Novartis AG (ADR) (NYSE:NVS) has risen 7.67% since September 7, 2016 and is uptrending. It has underperformed by 9.03% the S&P500.The move comes ...
Amg National Trust Bank Trimmed By $801576 Its Novartis AG Sponsored Adr ...  High Point Observer
Fdx Advisors Lifted Position in Novartis AG Sponsored Adr (NVS) as Shares ...  BZ Weekly
Cullen Capital Management Has Raised By $49.35 Million Its Novartis Ag (Adr ...
Cullen Capital Management Llc increased Novartis Ag (Adr) (NVS) stake by 573.66% reported in 2016Q4 SEC filing. Cullen Capital Management Llc acquired 685,410 shares as Novartis Ag (Adr) (NVS)'s stock rose 4.17%. The Cullen Capital Management ...
First Fiduciary Investment Counsel Lifted Novartis Ag Adr (NVS) Position By ...  NormanObserver.com
Quadrant Capital Management Has Decreased Its Novartis Ag Adr (NVS) Position ...  FlintDaily.com
Capital World Investors Has Cut By $36.02 Million Its Novartis Ag Namen Adr ...
Capital World Investors decreased Novartis Ag Namen Adr (NVS) stake by 25.86% reported in 2016Q4 SEC filing. Capital World Investors sold 500,307 shares as Novartis Ag Namen Adr (NVS)'s stock rose 4.17%. The Capital World Investors holds 1.43M ...
Cullen Capital Management Has Upped Its Novartis Ag (Adr) (NVS) Holding by $49 ...
Cullen Capital Management Llc increased its stake in Novartis Ag (Adr) (NVS) by 573.66% based on its latest 2016Q4 regulatory filing with the SEC.
This Analyst Predicts Bullish Growth Outlook For Incyte
Argus said in a note that it sees bullish growth outlook for Incyte Corporation (NASDAQ: INCY) given its solid late-stage pipeline and key strategic R&D partnerships with companies such as Merck & Co.